[Fernand Widal syndrome and sulfite intolerance. Therapeutic problems in general and ORL problems in particular].
Asthma from intolerance of sulphites has been the subject of clinical work by our team since 1984. In 1986, we advised that asthma from sulphite intolerance was more frequent in patients who presented with illness from aspirin or the Fernand Widal syndrome. So it has emerged that there are clear therapeutic problems since sulphites as preservatives are present in other forms in some anti-allergy drugs, anti-histamines used for ORL.
Drouet
M
M
Laboratoire d'Immuno-Allergologie, CHRU, Angers.
Sabbah
A
A
Le Sellin
J
J
Bonneau
J C
JC
Fourrier
E
E
D001241:Aspirin / Q000009:adverse effects*; D001249:Asthma / Q000139:chemically induced*; D003430:Cross-Sectional Studies; D004342:Drug Hypersensitivity / Q000453:epidemiology / Q000209:etiology*; D005602:France / Q000453:epidemiology; D006801:Humans; D009298:Nasal Polyps / Q000139:chemically induced*; D011310:Preservatives, Pharmaceutical / Q000009:adverse effects; D012221:Rhinitis, Allergic, Perennial / Q000139:chemically induced*; D013447:Sulfites / Q000009:adverse effects*; D013577:Syndrome
D011310:Preservatives, Pharmaceutical; D013447:Sulfites; D001241:Aspirin
Syndrome de Fernand Widal et intolérance aux sulfites. Problèmes thérapeutiques en général et ORL en particulier.